Cannabis
CENTR Brands Corp. Announces 5th Consecutive Quarter of Growth & Record New Sales
Vancouver, British Columbia–(Newsfile Corp. – October 28, 2020) – CENTR Brands Corp.(CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the “Company“) is pleased to make the following announcements:
Q1 2021 Results: The Company reported gross sales of USD $209,591 for Q1 2020, with the full financial statements for the quarter and related management’s discussion and analysis (“MD&A“) available under the Company’s SEDAR profile at www.sedar.com. This is the fifth consecutive quarter of increasing sales since the company launched CENTR.
Record Preliminary Q2 Sales. Based on preliminary financial data, the Company today announced that Q2 sales and shipments of CENTR have already reached over USD $365,000 for the current quarter ending November 30, 2020, an increase of 70% over today’s reported Q1 numbers.
“Even with more than one month left in this quarter, we have seen vast levels of sales growth”, said the Company’s CEO, Joseph Meehan. “While we knew that sales were increasing, the entire CENTR team is thrilled to see that consumers are discovering CENTR so quickly.”
The Company expects to release second quarter 2021 earnings in January 2021, in line with reporting requirements.
About CENTR Brands Corp. CENTR Brands Corp. is a functional beverage company which develops and markets non-alcoholic beverages for the global market. The Company’s first product, named CENTR, is a sparkling, low-calorie, CBD beverage.
For further information, contact Joseph Meehan at [email protected].
On behalf of the Board,
CENTR BRANDS CORP.
/s/ Joseph Meehan
Joseph Meehan, Chief Executive Officer
This press release contains sales figure estimates for the second quarter and “Forward-Looking Statements” within the meaning of applicable Canadian securities laws. Actual results may differ from those indicated as a result of finalization of the Company’s financial statements as well as other risks and uncertainties. Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/66999
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE3 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Cannabis2 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical